Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Zineh

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Clinical Pharmacology and Therapeutics|September 30, 2022
Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and ApprovalDavid G Strauss, Yow-Ming Wang, Jeffry Florian, et al.
Pharmacotherapy|March 3, 2006
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failureTobias Gerhard, Issam Zineh, Almut G Winterstein, et al.
Clinical Pharmacology and Therapeutics|August 24, 2023
A Multistakeholder Perspective on Advancing Individualized TherapeuticsMichael Pacanowski, Julia Vitarello, Insoo Hyun, et al.
Clinical and Translational Science|July 17, 2024
How debunking biases in research and development decisions could lead to more equitable healthcare?Benjamin Weber, Issam Zineh, Richard Lalonde, et al.
Pharmacogenomics|January 19, 2013
Consistency of drug-drug and gene-drug interaction information in US FDA-approved drug labelsDaniela J Conrado, Hobart L Rogers, Issam Zineh, et al.
Clinical Pharmacology and Therapeutics|September 8, 2020
Elucidating the Impact of Immunogenicity Assessment Postapproval: A Targeted Analysis of Immunogenicity Postmarketing Requirements and CommitmentsDaphne Guinn, Rajanikanth Madabushi, Yow-Ming Wang, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 2006
Common laboratory methods in pharmacogenomics studiesChristina L Aquilante, Issam Zineh, Amber L Beitelshees, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Qualifying biomarkers for use in drug development: a US Food and Drug Administration overviewJanet Woodcock, Shaavhree Buckman, Federico Goodsaid, et al.
Diabetes Care|December 19, 2008
Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetesIssam Zineh, Amber L Beitelshees, Janet H Silverstein, et al.
Clinical and Translational Science|February 22, 2019
Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved DrugsRobert N Schuck, Michael Pacanowski, Sarah Kim, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|September 30, 2022
Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and ApprovalDavid G Strauss, Yow-Ming Wang, Jeffry Florian, et al.
Pharmacotherapy|March 3, 2006
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failureTobias Gerhard, Issam Zineh, Almut G Winterstein, et al.
Clinical Pharmacology and Therapeutics|August 24, 2023
A Multistakeholder Perspective on Advancing Individualized TherapeuticsMichael Pacanowski, Julia Vitarello, Insoo Hyun, et al.
Clinical and Translational Science|July 17, 2024
How debunking biases in research and development decisions could lead to more equitable healthcare?Benjamin Weber, Issam Zineh, Richard Lalonde, et al.
Pharmacogenomics|January 19, 2013
Consistency of drug-drug and gene-drug interaction information in US FDA-approved drug labelsDaniela J Conrado, Hobart L Rogers, Issam Zineh, et al.
Clinical Pharmacology and Therapeutics|September 8, 2020
Elucidating the Impact of Immunogenicity Assessment Postapproval: A Targeted Analysis of Immunogenicity Postmarketing Requirements and CommitmentsDaphne Guinn, Rajanikanth Madabushi, Yow-Ming Wang, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 2006
Common laboratory methods in pharmacogenomics studiesChristina L Aquilante, Issam Zineh, Amber L Beitelshees, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Qualifying biomarkers for use in drug development: a US Food and Drug Administration overviewJanet Woodcock, Shaavhree Buckman, Federico Goodsaid, et al.
Diabetes Care|December 19, 2008
Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetesIssam Zineh, Amber L Beitelshees, Janet H Silverstein, et al.
Clinical and Translational Science|February 22, 2019
Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved DrugsRobert N Schuck, Michael Pacanowski, Sarah Kim, et al.
Pageof 13